Consortium Study on 1280 Breast Carcinomas: Allelic Loss on Chromosome 17 Targets Subregions Associated with Family History and Clinical Parameters

Bruce Ponder , Peter Devilee , Jorunn Eyfjörd , Rosa Barkardottir
Cancer Research 58 ( 5) 1004 -1012

80
1998
BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability

Solveig Gretarsdottir , Jorunn E. Eyfjörd , Rut Valgardsdottir , Margret Steinarsdottir
Cancer Research 58 ( 5) 859 -862

131
1998
Somatic p53 Mutations in Human Breast Carcinomas in an Icelandic Population: A Prognostic Factor

Jorunn E. Eyfjörd , Steinunn Thorlacius , Anne-Lise Börresen
Cancer Research 53 ( 7) 1637 -1641

109
1993
p53 abnormalities and genomic instability in primary human breast carcinomas.

Jorunn E. Eyfjörd , Rut Valgardsdottir , Margret Steinarsdottir , Helga M. Ögmundsdottir
Cancer Research 55 ( 3) 646 -651

95
1995
Screening for germ line TP53 mutations in breast cancer patients.

Birgitte Smith-Sørensen , Lars Ottestad , Eivind Hovig , Jorunn Eyfjörd
Cancer Research 52 ( 11) 3234 -3236

167
1992
Evaluation of Association of HNF1B Variants with Diverse Cancers: Collaborative Analysis of Data from 19 Genome-Wide Association Studies

Katherine S Elliott , Eleftheria Zeggini , Mark I McCarthy , Julius Gudmundsson
PLoS ONE 5 ( 5) e10858

27
2010
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Thorgeir E Thorgeirsson , Frank Geller , Patrick Sulem , Thorunn Rafnar
Nature 452 ( 7187) 638 -642

1,612
2008
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.

Simon N Stacey , Andrei Manolescu , Patrick Sulem , Thorunn Rafnar
Nature Genetics 39 ( 7) 865 -869

697
2007
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes

Julius Gudmundsson , Patrick Sulem , Valgerdur Steinthorsdottir , Jon T Bergthorsson
Nature Genetics 39 ( 8) 977 -983

836
2007
The effective size of the Icelandic population and the prospects for LD mapping: inference from unphased microsatellite markers.

Thomas Bataillon , Thomas Mailund , Steinunn Thorlacius , Eirikur Steingrimsson
European Journal of Human Genetics 14 ( 9) 1044 -1053

9
2006
Male breast cancer in Iceland

Jon G Jonasson , Bjarni A Agnarsson , Steinunn Thorlacius , Jorunn E Eyfjord
International Journal of Cancer 65 ( 4) 446 -449

24
1996
BRCA2 mutation carriers, reproductive factors and breast cancer risk

Laufey Tryggvadottir , Elinborg J Olafsdottir , Sigfridur Gudlaugsdottir , Steinunn Thorlacius
Breast Cancer Research 5 ( 5) 1 -8

54
2003
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains

Anne-Lise Børresen , Tone Ikdahl Andersen , Jorunn E. Eyfjörd , Renee S. Cornelis
Genes, Chromosomes and Cancer 14 ( 1) 71 -75

162
1995
Abstract PR-7: A European genome-wide association study of urinary bladder cancer

Lambertus Kiemeney , Steinunn Thorlacius , Patrick Sulem , Frank Geller
Cancer Prevention Research 1

2008
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

Steinunn Thorlacius , Gudridur Olafsdottir , Laufey Tryggvadottir , Susan Neuhausen
Nature Genetics 13 ( 1) 117 -119

460
1996
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.

Xifeng Wu , Yuanqing Ye , Lambertus A Kiemeney , Patrick Sulem
Nature Genetics 41 ( 9) 991 -995

210
2009
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

Julius Gudmundsson , Patrick Sulem , Thorunn Rafnar , Jon T Bergthorsson
Nature Genetics 40 ( 3) 281 -283

350
2008
A population-based study on the familial aggregation of cutaneous malignant melanoma in Iceland.

Bjarki Jonsson Eldon , Steinunn Thorlacius , Thorvaldur Jonsson , Jon Gunnlaugur Jonasson
European Journal of Cancer 42 ( 7) 922 -926

5
2006
BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.

Thorunn Rafnar , Kristrun R. Benediktsdottir , Bjarki J. Eldon , Thorgeir Gestsson
European Journal of Cancer 40 ( 18) 2788 -2793

43
2004